Participants note sharp drops in bariatric procedures and chronic disease management, prompting surgeons and some psychiatrists to advertise harder or shift toward prescribing the drugs themselves. One major manufacturer is expected to stay profitable through pipeline products while overall industry revenue may shrink. Several users view reduced surgeries and better health outcomes as clear wins for patients, though others point out increased visits for monitoring, labs, and follow-up cosmetic work.
What this discussion establishesOne participant argues that GLP-1 users actually generate more healthcare encounters through labs, check-ins, and new procedures, countering the claim that overall demand will fall.
Still openWhether cheaper generics will lead health systems to prescribe the drugs more broadly once patents expire.
Nothing here is advice.
The quote about consumers engaging with their health is obvious and not surprising.
GLPs are set to cut into hospital and surgeon revenue through fewer joint replacements, better heart health, and reduced chronic conditions. It is worth feeling sorry for the big companies, physicians, and facilities whose earnings will take a hit.
It will be interesting to watch what occurs once patents expire. In the UK these medications are available privately but hard to obtain through the public system, likely due to cost. If they end up saving the system money overall, they might become much easier to get once inexpensive versions appear.
One of the big manufacturers will probably be fine. Newer versions are expected in a couple of years so their earnings should hold up. The chance of fewer chronic conditions is the real benefit amid any industry changes, and that part is welcome.
It would be useful to know how much of the profits in pharma and medicine come from obesity-related conditions. That may explain why prices are being kept high now. In a few years the whole business could be much smaller. It is possible the country could end up with far fewer overweight people.
The phrasing about reshaping how providers generate revenue treats revenue as the main goal. Ideally providers would bring in less money. If people require less care overall, that should be viewed positively.
The reported drop in bariatric procedures looks like a win for patients since surgery costs more and carries higher risks. Avoiding operations in multiple areas would be beneficial. Personal experience with complications from heart surgery leading to further health decline makes the alternative appealing.
People needing less care is positive unless you hold shares in medical companies.
The same thought occurred, yet many still view these drugs negatively because of scare stories. Early online comments called one version a dangerous substance linked to serious side effects. After checking better sources the view changed, though one option is still avoided in favor of another. Some people will remain overweight rather than look into it properly.
That is why shares in the leading manufacturer might be the better choice instead.
In a big city with a major hospital system, local bariatric surgeons have been pushing hard with ads and seminars claiming their work is superior. They appear worried about losing business and it is unclear what they will switch to next.
Watching the show about extreme weight cases makes one hope the featured doctor loses that line of work. Handing out basic diet sheets and one counseling visit does not solve the problems for most people at that size.
A quick search shows that doctor has started offering a program combining the medications with a structured eating plan and follow-up, apparently recognizing the shift in demand.
The simple move is to focus on procedures to remove excess skin, since demand for that will rise.
That update was new information.
The change is recent. Operating on patients at very high weights carries real risks, which is why weight reduction was often required first. It would not be surprising if the medications are now used for the highest-risk cases.
In this area some psychiatrists are moving toward mainly providing these medications. Bariatric surgeons may follow a similar path or offer both surgery and the injections to capture the business either way.
The doctor on that show never appeared healthy and seemed to carry extra weight. Perhaps treatment is being used now as well. The approach of shaming patients clearly showed they lacked control over eating and biology, and that method does not produce results.
The program is difficult to watch because of scenes of people eating large amounts while others assist them. The excuses offered for lack of progress are frustrating. It is sad to see the beliefs some people hold about their situation. Similar shows focused on skin issues are also avoided.
It is not unusual for Americans to link new things with negative forces. Growing up, certain games were treated as forbidden for similar reasons.
Efforts to criticize body size continue in many places. It raises the question of what critics will do once fewer people fit the profile they target.
Those who dislike will continue to do so.
There are many other ways to spend time.
More frequent visits occur because of active health management, including regular tests and check-ups. Additional procedures such as skin removal become considerations after significant weight change. Other people mention interest in joint repairs or similar steps to improve mobility.
Medical experts could end up switching their focus areas though that might be all the disruption in healthcare fields. A surgeon dealing with stomach issues would experience shifts in their routine. Certain other experts might keep their main area but alter their everyday tasks. Those handling cosmetic operations would switch to alternative methods. Given the existing delays in American healthcare reducing total need by a fifth won't lead to fewer positions only a redistribution of roles. American healthcare has issues already. Extended delays to see someone for just a short time frequently subpar care and erratic expensive charges. Visiting a practitioner focused on overall function who avoids coverage plans means the appointment lasts longer includes more attention and leads to superior outcomes. It's interesting how having enough time for discussion with the practitioner enhances the care and the end results.
I've been really tempted to buy a large number of shares. I believe it was around that level yesterday.
Since cash is short I grabbed just a small slice of one stock back when the cost was sky high. Still I picked up a few shares in something different that started cheap but climbed a lot now laughing hard. These days my main spending goes toward getting healthier laughing.
During a 2011 holiday meal with my relatives I mentioned this brand new digital money idea. Yet I failed to acquire some, sadly 😭
I figured I'd come up with those tanning wipes ahead of everyone else 😂😂😂 Totally feel what you're dealing with!
This sounds familiar! It happened during the holidays back in 2016. My sibling picked up quite a few units of that digital money and kept going on about its possible growth. I called it the dumbest idea around and made clear I wanted nothing to do with imaginary cash that sits only on screens. These days he's sitting on serious wealth thanks to what he put in years earlier. Every December he brings the whole thing up again.
To balance out this sad account somewhat, let me share that my father died calmly during sleep. Reaching eighty, he outlived his brother and dad by roughly fifteen years. He had scheduled a meal with a woman he knew just two days prior, showing he was still romantically active. On top of that, he continued drumming with his jazz ensemble at performances.
I tend to skim past pieces heavy on financial angles, yet these treatments have started shifting the landscape already and will do even more over time. Operations for weight issues have dropped noticeably in the past year. Even though the injections work well, procedures still come out ahead for lasting results on conditions like blood sugar problems or cardiac risks. Deciding whether to go ahead with surgery right now raises doubts, since combining the shots could deliver similar results without the recovery hassle or lasting downsides from going under the knife. Plenty of recent studies from surgical teams highlight how operations beat the shots, which makes sense given they see their work at risk. The sticking point in all the value analyses comes down to how much the shots cost upfront. They cut future medical spending sharply, even with extra checkups, because the real expenses hit with serious hospital stays or later-life care. A big chunk of total spending happens near the end anyway. Cutting or postponing events like cardiac episodes, vessel procedures, tumors, and possibly memory loss would trim those bills dramatically, though the returns take years to show up for anyone footing the bill. The initial outlay stays steep and continuous, so the savings need to add up enough over that span to justify it. My own system shows no sign of broad coverage soon, since supporting the shots for a large share of people would blow the budget, leaving any help limited to one option and aimed only at the highest-risk cases where benefits arrive faster. Costs have already fallen sharply in places that launched their own versions, and at least one type will lose protection in many spots before long, though not everywhere. The pipeline of similar compounds looks crowded, with some we know about already and others still a couple years off. Not every candidate will reach the market, and competition should push prices down eventually, unless makers in one region skip selling here and leave us paying more while others get lower rates. That setup would likely spark a fresh round of unofficial channels for these treatments.
This comes exactly when the broad medical coverage starts operating.
Australia already features a fairly similar setup, along with extra private healthcare choices, yet public money won't cover the newer option and only supports the older drug for diabetes cases or severe weight problems in folks who've suffered a prior cardiac event.
Yeah, yet the medical fields here stand apart from one another. Those performing weight loss procedures concentrate mainly on digestive matters, whereas those excising loose tissue work in cosmetic reconstruction. Medical centers might redirect their focus between such operations, though individual doctors cannot manage the switch absent major further preparation.
If you have tried it, this topic is still open. Sign in to reply — it takes a minute.